PainReform receives Nasdaq notice regarding minimum stockholders’ equity requirement

ChitogenX reports Q3 results (OTCMKTS:CHNXF)

  • ChitogenX press release (OTCQB:CHNXF): Net loss of $0.6 million in Q3-25, compared to net loss of $0.8 million in Q3-24, a decrease of 23%.
  • Total liabilities of $7.7 million as at the end of Q3-25 compared to $6.7 million as at year-end 2024, with a working capital deficit of $7.5 million compared to $3.0 million for the same periods, as a result of all existing notes and debentures now presented as current.

Leave a Comment

Your email address will not be published. Required fields are marked *